Delivery Order SPE2DP20D0002-SPE2DP25F8211
Award Date
6/16/25
Potential Completion Date
6/24/25
Potential Value
$495K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Adenovirus Type 4 vaccines, which are critical medical products used in military immunization programs. The contract has a ceiling value of $165,156.93 and a completion date of June 24, 2025. Teva Pharmaceuticals USA, Inc. has established itself as a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which is a critical product for military immunization programs. The contract has a ceiling value of $660,627.72 and a period of performance ending on June 24, 2025. Teva Pharmaceuticals USA, Inc. has established itself as a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer. The contract, valued at $990,941.58, is for the delivery of Adenovirus Type 4 vaccine, which is used in military immunization programs. The contract has an ultimate completion date of May 20, 2025. Teva Pharmaceuticals USA, Inc. has established itself as a key supplier to federal healthcare programs,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which is critical for military immunization programs. The contract has a ceiling value of $165,156.93 and a period of performance through April 29, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $825,784.65 contract is for the delivery of Adenovirus Type 4 vaccines, which are critical medical products for military immunization programs. Teva is a key supplier to federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD),...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $495,470.79 contract is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a key supplier to federal healthcare programs, providing essential pharmaceutical products to agencies such as the Department of Veterans...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a performance period through March 25, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $3,176,094.60, is for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and is a major supplier of critical...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $990,941.58, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has an ultimate completion date of April 29, 2025. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva...
This is a $330,313.86 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a key supplier of critical medical products to federal healthcare programs, including the Department of Veterans Affairs (VA), Department...